Trial Outcomes & Findings for Bicarbonate in Patients With Out-of-hospital Cardiac Arrest (NCT NCT02303548)

NCT ID: NCT02303548

Last Updated: 2022-03-25

Results Overview

Percentage of Participants with Return of Spontaneous Circulation (ROSC)

Recruitment status

COMPLETED

Study phase

PHASE2

Target enrollment

50 participants

Primary outcome timeframe

checked during CPR, duration of ROSC >20 min

Results posted on

2022-03-25

Participant Flow

Participant milestones

Participant milestones
Measure
1 (Sodium Bicarbonate)
Sodium bicarbonate 50cc (50mEq) intravenous injection over 2 min Sodium bicarbonate: Administer Sodium bicarbonate 50 mEq IV over 2 minutes
2 (Normal Saline)
Normal saline 50cc intravenous injection over 2 min Normal saline: Placebo
Overall Study
STARTED
25
25
Overall Study
COMPLETED
25
25
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
1 (Sodium Bicarbonate)
n=25 Participants
Sodium bicarbonate 50cc (50mEq) intravenous injection over 2 min Sodium bicarbonate: Administer Sodium bicarbonate 50 mEq IV over 2 minutes
2 (Normal Saline)
n=25 Participants
Normal saline 50cc intravenous injection over 2 min Normal saline: Placebo
Total
n=50 Participants
Total of all reporting groups
Age, Continuous
65.5 years
STANDARD_DEVIATION 16.4 • n=25 Participants
64.1 years
STANDARD_DEVIATION 15.4 • n=25 Participants
64.8 years
STANDARD_DEVIATION 16.0 • n=50 Participants
Sex: Female, Male
Female
7 Participants
n=25 Participants
4 Participants
n=25 Participants
11 Participants
n=50 Participants
Sex: Female, Male
Male
18 Participants
n=25 Participants
21 Participants
n=25 Participants
39 Participants
n=50 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
South Korea
25 Participants
n=25 Participants
25 Participants
n=25 Participants
50 Participants
n=50 Participants
pH
6.99 units on a scale
n=25 Participants
6.90 units on a scale
n=25 Participants
6.95 units on a scale
n=50 Participants
Shockable pre-hospital rhythm
7 participants
n=25 Participants
3 participants
n=25 Participants
10 participants
n=50 Participants

PRIMARY outcome

Timeframe: checked during CPR, duration of ROSC >20 min

Percentage of Participants with Return of Spontaneous Circulation (ROSC)

Outcome measures

Outcome measures
Measure
1 (Sodium Bicarbonate)
n=25 Participants
Sodium bicarbonate 50cc (50mEq) intravenous injection over 2 min Sodium bicarbonate: Administer Sodium bicarbonate 50 mEq IV over 2 minutes
2 (Normal Saline)
n=25 Participants
Normal saline 50cc intravenous injection over 2 min Normal saline: Placebo
Return of Spontaneous Circulation (ROSC)
4 ROSC percents of each group
16 ROSC percents of each group

Adverse Events

1 (Sodium Bicarbonate)

Serious events: 25 serious events
Other events: 25 other events
Deaths: 24 deaths

2 (Normal Saline)

Serious events: 24 serious events
Other events: 25 other events
Deaths: 21 deaths

Serious adverse events

Serious adverse events
Measure
1 (Sodium Bicarbonate)
n=25 participants at risk
Sodium bicarbonate 50cc (50mEq) intravenous injection over 2 min Sodium bicarbonate: Administer Sodium bicarbonate 50 mEq IV over 2 minutes
2 (Normal Saline)
n=25 participants at risk
Normal saline 50cc intravenous injection over 2 min Normal saline: Placebo
Nervous system disorders
Severe hypoxic brain injury
100.0%
25/25 • Number of events 25
96.0%
24/25 • Number of events 24

Other adverse events

Other adverse events
Measure
1 (Sodium Bicarbonate)
n=25 participants at risk
Sodium bicarbonate 50cc (50mEq) intravenous injection over 2 min Sodium bicarbonate: Administer Sodium bicarbonate 50 mEq IV over 2 minutes
2 (Normal Saline)
n=25 participants at risk
Normal saline 50cc intravenous injection over 2 min Normal saline: Placebo
Nervous system disorders
Severe hypoxic brain injury (<6 mo)
100.0%
25/25 • Number of events 25
100.0%
25/25 • Number of events 25

Additional Information

Director of Clinical Trials

Asan Medical Center

Phone: 8230103350

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place